Absci (ABSI) Notes Payables (2020 - 2026)
Absci's (ABSI) quarterly Notes Payables came in at $413000.0 in Q1 2026, down 83.77% year-on-year from $2.5 million in Q1 2025, and down 52.69% quarter-over-quarter from $873000.0 in Q4 2025.
Absci (ABSI) Notes Payables (2020 - 2026) Analysis & Trends
Absci has disclosed Notes Payables across 7 years of filings, most recently posting $413000.0 for Q1 2026.
- Notes Payables for Q1 2026 came in at $413000.0, down 83.77% year-over-year; the trailing twelve-month figure through Mar 2026 was $413000.0 (down 83.77% YoY), and the FY2025 annual result was $873000.0, down 68.06% from the prior year.
- Notes Payables came in at $413000.0 for Q1 2026 at Absci, down from $873000.0 in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $3.3 million in Q1 2024 to a low of $413000.0 in Q1 2026.
- The 5-year median for Notes Payables is $2.7 million (2024), against an average of $2.5 million.
- Across the five-year window, Notes Payables soared 47.31% in 2023 and sank 83.77% in 2026, its largest moves.
- Absci's Notes Payables stood at $2.9 million in 2022, then advanced by 10.59% to $3.3 million in 2023, then decreased by 16.11% to $2.7 million in 2024, then tumbled by 68.06% to $873000.0 in 2025, then tumbled by 52.69% to $413000.0 in 2026.
- The last three Notes Payables figures came in at $413000.0 (Q1 2026), $873000.0 (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Absci | 1.13 Bn | 1.01 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 413,000.00 |
| Dec 31, 2025 | 873,000.00 |
| Sep 30, 2025 | 1.31 Mn |
| Jun 30, 2025 | 1.99 Mn |
| Mar 31, 2025 | 2.54 Mn |
| Dec 31, 2024 | 2.73 Mn |
| Sep 30, 2024 | 3.27 Mn |
| Jun 30, 2024 | 3.12 Mn |
| Mar 31, 2024 | 3.30 Mn |
| Dec 31, 2023 | 3.26 Mn |
| Sep 30, 2023 | 3.21 Mn |
| Jun 30, 2023 | 3.15 Mn |
| Mar 31, 2023 | 3.08 Mn |
| Dec 31, 2022 | 2.95 Mn |
| Sep 30, 2022 | 2.35 Mn |
| Jun 30, 2022 | 2.14 Mn |
| Mar 31, 2022 | 2.40 Mn |
| Dec 31, 2021 | 2.40 Mn |
| Sep 30, 2021 | 2.40 Mn |
| Jun 30, 2021 | 1.58 Mn |